bioMerieux (OTCMKTS:BMXMF) Short Interest Update

bioMerieux (OTCMKTS:BMXMF) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totaling 85,800 shares, a decline of 37.8% from the August 31st total of 137,900 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 858.0 days. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 858.0 days.

bioMerieux Stock Performance

Shares of bioMerieux stock opened at $135.01 on Tuesday. The business has a fifty day simple moving average of $140.78 and a 200-day simple moving average of $136.27. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08. bioMerieux has a 12 month low of $100.50 and a 12 month high of $152.00.

About bioMerieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.